Edition:
United Kingdom

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

70.36USD
22 Nov 2017
Change (% chg)

$4.56 (+6.93%)
Prev Close
$65.80
Open
$66.28
Day's High
$71.34
Day's Low
$64.94
Volume
135,749
Avg. Vol
145,197
52-wk High
$74.42
52-wk Low
$25.08

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 5.89 -0.862
Mar '17 5.84 -0.843
FY 2016 Dec '16 7.69 -0.747
Sep '16 6.16 -0.618
Jun '16 7.07 -0.695
Mar '16 6.86 -0.572
FY 2015 Dec '15 4.64 -0.576
Sep '15 3.43 -0.471
Jun '15 2.69 -0.811
Mar '15 0.65 -8.234
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 8 4.99 8.10 1.12 6.34
Quarter Ending Mar-18 6 4.07 6.00 1.12 --
Year Ending Dec-17 9 24.67 28.00 20.92 26.83
Year Ending Dec-18 9 13.89 29.40 1.70 23.73
Earnings (per share)
Quarter Ending Dec-17 9 -1.12 -1.02 -1.37 -0.99
Quarter Ending Mar-18 7 -1.15 -0.96 -1.41 --
Year Ending Dec-17 9 -3.81 -3.71 -4.06 -4.20
Year Ending Dec-18 9 -4.87 -4.09 -5.93 -4.55
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 89.23 32.96
P/E High - Last 5 Yrs. -- 293.78 45.57
P/E Low - Last 5 Yrs. -- 94.62 24.35
Beta -- 0.85 0.89
Price to Sales (TTM) 101.33 86.57 5.25
Price to Book (MRQ) 6.92 13.59 5.40
Price to Tangible Book (MRQ) 6.93 13.47 6.74
Price to Cash Flow (TTM) -- 76.93 23.58
% Owned Institutions -- 6.31 1.29

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.27 1.49
Dividend 5 Year Growth Rate -- 1.88 5.23
Payout Ratio(TTM) -- 17.27 43.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -16.63 437.54 8.84
Sales (TTM) vs TTM 1 Yr. Ago 16.37 70.22 5.41
Sales - 5 Yr. Growth Rate -- 33.80 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.91 29.92 19.37
EPS (TTM) vs TTM 1 Yr. Ago -32.61 -- --
EPS - 5 Yr. Growth Rate -- 43.61 10.96
Capital Spending - 5 Yr. Growth Rate -- 41.13 15.32

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.69 2.20
Current Ratio (MRQ) 13.07 5.29 3.00
LT Debt to Equity (MRQ) 0.18 18.84 10.82
Total Debt to Equity (MRQ) 0.71 20.43 14.95
Interest Coverage (TTM) -103.52 -113.10 33.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.40 54.68
Gross Margin - 5 Yr. Avg. -- 51.61 52.16
EBITD Margin (TTM) -387.82 -- --
EBITD - 5 Yr. Avg -- -233.74 15.51
Operating Margin (TTM) -394.04 -434.91 9.27
Operating Margin - 5 Yr. Avg. -- -249.72 11.18
Pre-Tax Margin (TTM) -388.91 -410.78 10.08
Pre-Tax Margin - 5 Yr. Avg. -- -249.03 11.61
Net Profit Margin (TTM) -388.91 -412.33 6.37
Net Profit Margin - 5 Yr. Avg. -- -251.97 7.88
Effective Tax Rate (TTM) -- 23.97 23.20
Effective Tax Rate - 5 Yr. Avg. -- 19.27 24.03

Efficiency

  Company industry sector
Revenue/Employee (TTM) 241,330 25,590,626 876,729,110
Net Income/Employee (TTM) -938,547 3,388,768 103,151,977
Receivable Turnover (TTM) 7.96 21.68 5.78
Inventory Turnover (TTM) -- 2.02 3.35
Asset Turnover (TTM) 0.08 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -31.52 -0.31 11.10
Return on Assets - 5 Yr. Avg. -- 0.00 12.57
Return on Investment (TTM) -34.88 2.53 14.58
Return on Investment - 5 Yr. Avg. -- 3.09 16.46
Return on Equity (TTM) -40.89 3.17 16.09
Return on Equity - 5 Yr. Avg. -- 6.58 17.62
  1 Year 3 Year 5 Year
Sales % 143.61 -- --
EPS (TTM) % 14.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Blueprint Medicines Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 26.74 22.37 89 53
13 Week 24.13 18.08 80 61
26 Week 48.03 36.78 85 69
52 Week 147.42 109.71 92 47
YTD 136.22 107.45 92 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 203
Total Shares Held: 39,712,283
3 Mo. Net Change: 239,632
# New Positions: 33
# Closed Positions: 17
# Increased Positions: 93
# Reduced Positions: 77
# Net Buyers: 16
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.